Symptom Management for Irritable Bowel Syndrome

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02079857

Enrollment

183

Registered

2014-03-06

Start date

2012-11-30

Completion date

2019-11-01

Last updated

2020-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable Bowel Syndrome

Brief summary

The objective of this study is to test the efficacy of a symptom management treatment strategy, Acupuncture/Moxibustion (Acu/Moxa), to improve the symptoms associated with Irritable Bowel Syndrome (IBS) in adults.

Interventions

OTHERSham acupuncture/Placebo moxa

Subjects will receive sham acupuncture/placebo moxa

OTHERStandard protocol

Subjects will receive a standard treatment

OTHERIndividualized protocol

Subjects will receive an individualized treatment

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Healthy volunteers

Inclusion criteria

* Men and women 18 to 70 years of age. * Diagnosis of IBS based on ROME III criteria. * Complete symptom diaries and return completed diaries at all sessions.

Exclusion criteria

* History of co-existing gastrointestinal, and/or gynecological, and/or urologic pathology. * Alarm symptoms according to ROME III. * Individuals currently receiving other types of complementary therapies. * Individuals with an acute medical condition requiring acute medical attention.

Design outcomes

Primary

Measure	Time frame
Symptom severity-abdominal pain	week 1

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026